InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Thursday, 05/11/2017 3:34:17 PM

Thursday, May 11, 2017 3:34:17 PM

Post# of 3504
"very close to commercializing its new drug" : https://www.insiderfinancial.com/cleveland-biolabs-inc-nasdaq-cbli-is-todays-biotech-focus/121534/

"Cleveland BioLabs is very close to commercializing its new drug Entolimod and has other drugs in Phase 2"

"In addition to this, the balance sheet looks very clean right now. The company showed in the last 10-k that it had about $15 million in total assets and only $3 million in total liabilities".

"has no long term debt, and 99% of its assets are short-term investments or cash on hand".

beside Russian Federation Ministry of Industry funding "has also received funding from the US Government".

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.